https://doi.org/10.55788/bb380984
Obesity is a known risk factor for OA and is associated with progression of knee OA. “But what we don’t know is whether weight loss is associated with a decreased incidence of knee OA in men and decreased progression of knee OA in men and women,” Dr Zubeyir Salis explained (University of New South Wales, Australia). Therefore, his study aimed to define the association between change in weight and the incidence and progression of radiographic knee OA [1].
Scores from knee radiographs at baseline and at 4 to 5 years of follow-up were obtained from 3 independent data sets (2 from the USA and 1 from the Netherlands). The exposure of interest was the change in BMI from baseline to 4 to 5 years of follow-up. To investigate the incidence of structural defects of knee OA, the researchers selected a total of 9,732 knees with a Kellgren-Lawrence (KL) grade of 0 (none) or 1 (doubtful) at baseline, named the incidence cohort, and determined the odds of having a KL grade at follow-up of 2 (minimal), 3 (moderate), or 4 (severe). To investigate progression, 6,084 knees were assessed with a KL grade at baseline of 2, 3, or 4 (the progression cohort), and the odds of increasing by 1 or more KL grades at follow-up were determined. “We also looked at the degeneration of individual radiographic features (i.e. joint space narrowing and osteophytes on the femoral and tibial surface) on the medial and lateral sides of the knees in both cohorts,” Dr Salis said. Here, degeneration was defined as an increase by 1 or more Osteoarthritis Research Society International (OARSI) grades.
Included were 4,842 participants in the incidence cohort and 3,216 participants in the progression cohort. Change in BMI was positively associated with both the incidence and progression of knee OA. “The change in BMI was also positively associated with narrowing of joint space on the medial but not the lateral compartment of the knee. However, there was no association between the change in BMI and osteophytes in both compartments,” Dr Salis commented.
These results could have an important public health impact. “We estimated that those who lost 1 BMI unit could reduce the incidence of knee radiographic OA by 13% and the progression of knee OA by 10%,” Dr Salis concluded.
- Salis Z, et al. Weight loss is associated with reduced incidence and progression of structural defects in knee osteoarthritis. OP0227, EULAR 2022 Congress, 1–4 June, Copenhagen, Denmark.
Copyright ©2022 Medicom Medical Publishers
Posted on
Previous Article
« How to treat enthesitis in 2022 Next Article
OA associated with alcohol and drug abuse »
« How to treat enthesitis in 2022 Next Article
OA associated with alcohol and drug abuse »
Table of Contents: EULAR 2022
Featured articles
Late-Breaking Oral Abstracts
TYK2 inhibition: the future of treating lupus erythematosus?
Psoriatic arthritis: significant improvement with bimekizumab
Baricitinib could open the door to oral treatment for juvenile idiopathic arthritis
Sarilumab for polymyalgia rheumatica led to sustained remission and fewer flares
Spotlight on Rheumatoid Arthritis
Comorbid depression comes with a profoundly higher mortality risk in RA
Preventive treatment with methotrexate benefits pre-RA patients with arthralgia
Risk factors for dementia in RA patients discovered
VTE in global registry data more common in JAK inhibitor-treated RA patients
Spondyloarthropathies – Novel Developments
How to treat enthesitis in 2022
Baseline cardiovascular risk linked to higher rates of MACE in PsA and PsO patients receiving tofacitinib
Treat-to-target dose reduction effective in spondyloarthritis
A novel oral treatment possibility for non-radiographic axSpA on the horizon
Many RA and PsA patients have problems with their sex life
What Is Hot in Osteoarthritis?
New treatments in osteoarthritis
OA associated with alcohol and drug abuse
Body mass index increase associated with structural changes in knee OA
What Is New in Lupus and Scleroderma
Inhibition of Bruton’s tyrosine kinase: a new way of approaching SLE?
Pregnancies in SLE: many complications for mothers and their unborn children
Lupus nephritis: Efficient treatment may reduce the risk of kidney disease advancement
Antifibrotic therapy with nintedanib is beneficial for patients with negative prognostic factors
Best of the Posters
Alarmingly low activity in patients with non-inflammatory and inflammatory rheumatic disease
High prevalence of fibromyalgia in patients with inflammatory bowel disease
Related Articles
December 1, 2022
Fast recapture of response with ozanimod after withdrawal in UC
November 6, 2024
Deucravacitinib treatment in lichen planopilaris
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com